TrialNutrients2021

Insulin/IGF-1 Signaling Is Downregulated in Barrett's Esophagus Patients Undergoing a Moderate Calorie and Protein Restriction Program: A Randomized 2-Year Trial.

Diletta Arcidiacono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.